MedImmune Presents Data Highlighting its Progressive Inflammatory Disease Portfolio at the 72nd Annual Meeting of the American College of Rh... (ract: 1346 -- Neutralizing I...)

HOME >> BIOLOGY >> TECHNOLOGY

MedImmune Presents Data Highlighting its Progressive Inflammatory Disease Portfolio at the 72nd Annual Meeting of the American College of Rheumatology

Date:10/23/2008

ract:

1346

-- Neutralizing IFN-alpha in SLE affects GMCSF, TNF-alpha, IL-10, IL1-beta

and BAFF signaling pathways - Brandon Higgs, Ph.D., Tuesday, October 28

from 9:00 a.m. - 11:00 a.m. in Hall A, Abstract: 1340

-- Memory T lymphocytes expressing the inducible costimulator (icos) are

required to maintain the secondary lymphoid tissue architecture in non

human primates - Gianluca Carlesso, Ph.D., Tuesday, October 28 from 9:00

a.m. - 11:00 a.m. in Hall A, Abstract: 1843

-- In vitro properties of CAM-3001, a human anti GM-CSF receptor antibody

for the treatment of patients with rheumatoid arthritis - Matthew

Sleeman, Ph.D., Tuesday, October 28 from 9:00 a.m. - 11:00 a.m. in Hall

A, Abstract: 1338

-- Use of a SOCS3 ex-vivopharmacodynamic quantitative RT-PCR assay for

CAM-3001, a new antibody therapy for the treatment of rheumatoid

arthritis - Jo Woods, Ph.D., Tuesday, October 28 from 9:00 a.m. - 11:00

a.m. in Hall A, Abstract: 1339

About MedImmune

MedImmune is a leading innovation-focused biotechnology company whose mission is to provide better medicines to patients, new medical options for physicians and rewarding careers to employees. Dedicated to advancing science and medicine to help people live better lives, the company is focused on infection, oncology, respiratory disease and inflammation, cardiovascular/ gastrointestinal disease and neuroscience. Headquartered in Gaithersburg, Maryland, MedImmune has approximately 3,000 employees worldwide and is the wholly owned biologics business for AstraZeneca plc (LSE: AZN.L, NYSE: AZN). For more information, visit MedImmune's website at http://www.medimmune.com.

SOURCE MedImmune
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3
Related biology technology :

1. MedImmune Licenses Reverse Genetics Technology to Hungarys Omninvest for Use in Influenza Vaccine Development and Production
2. MedImmune Expands R&D Capacity with New Research Facility in Cambridge, U.K.
3. MedImmune Presents Data at AAP National Conference & Exhibition Demonstrating Burden of RSV Disease
4. Pinnacle Biologics Announces Stock Purchase Agreement With MedImmune
5. MedImmunes Brian Rosen Honored by Montgomery County Chamber at 49th Annual Awards Dinner
6. Depth of MedImmunes Respiratory Disease Research Program Highlighted at Annual Meeting of the American Thoracic Society
7. MedImmune Fortifies Strategic Scientific Portfolio Management and International Leadership With New Executive Appointments
8. MedImmune Presents Data Highlighting its Progressive Oncology Portfolio at Annual Meeting of the American Association For Cancer Research
9. Seneca Valley High School Student Receives Science Award From MedImmune
10. MedImmune Strengthens Key Leadership Functions to Further Support Recently Expanded, Rapidly Advancing Product Portfolio
11. MedImmune Submits Biologics License Application to FDA for Motavizumab

Post Your Comments:

(Date:2/9/2010)... Feb. 9 ... research report is available in its ... Laboratory Services Market (Growth Opportunities, Competitive ... ,, http://www.reportlinker.com/p0176223/The-Clinical-Laboratory-Services-Market-Growth-Opportunities-Competitive-Analysis-and-Competitor-Profiles.html ,, Clinical ... the health industry. It is estimated ...

(Date:2/9/2010)... Ariz. , Feb. 9 A ... joined an international research program to study an investigational ... cramps, or dysmenorrhea, a condition that affects between 45 ... the United States . Although not life threatening, ... one of the leading causes of absenteeism from work ...

(Date:2/9/2010)... NEW YORK , Feb. 9 /PRNewswire-Asia-FirstCall/ ... or the "Company"), an international,biopharmaceutical company with operations ... that its stem cell collection network has expanded ... addition of the physician group at Westlake,Orthopaedics Spine ... The Company is on,track to achieve its ...

(Date:2/8/2010)... lifted off from NASA’s Kennedy Space Center this morning, carrying ... biotech company created to use microgravity to develop the foundation ... ... February 8, 2010 -- Space Shuttle Endeavor lifted off from ... eighth scientific payload for Astrogenetix, a commercial biotech company created ...

[0] Reportlinker Adds the Clinical Laboratory Services Market (Growth Opportunities, Competitive Analysis and Competitor Profiles)[0] Peoria Clinical Research Center Tests Investigational Drug to Treat Painful Menstrual Cramps [0] Busy Southwestern Orthopedic Practice Joins the NeoStem Stem Cell Collection Network [0] Astrogenetix Continues MRSA Vaccine Development Onboard Endeavor

... Edwards Lifesciences,Corporation (NYSE: EW ), the world ... the first three human implants of the next-generation,Edwards ... M.D.,director of the cath lab and cardiac intervention ... "Edwards is proud to extend our leadership in ...

... SAN DIEGO, March 5 Ardea Biosciences, Inc.,(Nasdaq: ... the Company,s corporate,headquarters and research laboratories to San ... Valley and will house the Company,s research,preclinical and ... our two southern California facilities to San Diego,s,biotechnology ...

... NEW YORK, March 5 Bristol-Myers Squibb,Company (NYSE: ... Board of Directors,has elected Jean-Marc Huet senior vice ... In this role, Mr. Huet will be,responsible for ... as the global financial operations of the organization ...

Other Biology Technology:Edwards Lifesciences Announces First Human Implants of Next-Generation Transcatheter Heart Valve 2 Edwards Lifesciences Announces First Human Implants of Next-Generation Transcatheter Heart Valve 3 Ardea Biosciences to Move Headquarters and R&D Laboratories to San Diego 2 Bristol-Myers Squibb Board Elects Jean-Marc Huet Senior Vice President and Chief Financial Officer 2 Bristol-Myers Squibb Board Elects Jean-Marc Huet Senior Vice President and Chief Financial Officer 3

Edwards Lifesciences Announces First Human Implants of Next-Generation Transcatheter Heart Valve Ardea Biosciences to Move Headquarters and R&D Laboratories to San Diego Bristol-Myers Squibb Board Elects Jean-Marc Huet Senior Vice President and Chief Financial Officer

(Date:2/9/2010)... been a model system for studying and understanding the ... that cause influenza, measles and rabies. , ... potential to be genetically modified to serve as an ... while sparing healthy cells, and as a potent vaccine ... occur, however, scientists must have an accurate picture of ...

(Date:2/9/2010)... N.Y. (February 8, 2010) - Autism Speaks, the ... released its annual list of the 10 most ... the previous year. Every year, Autism Speaks documents ... the causes and treatment for autism spectrum disorders, ... significant research achievements to have impacted autism during ...

(Date:2/9/2010)... Feb. 9 Fujitsu ... of innovative computer products including peripherals, biometric security ... the luxurious new Fairmont Pacific Rim ... is using the new Fujitsu WT-A511 UHF-Band RFID ... its inventory of 10,000 employee uniforms and 25,000 ...

[0] Researchers reveal 3-D structure of bullet-shaped virus with potential to fight cancer, HIV [0] Autism Speaks presents the top ten autism research findings of 2009 [0] New Fujitsu UHF RFID Technology Implemented at Fairmont Pacific Rim Hotel for Advanced Inventory Monitoring

... will soon have access to a powerful new type ... system created from the seamless integration of state-of-the-art medical ... effort from Alexander Tsiaras, Anatomical Travelogue, will allow users ... complex network of arteries and veins and as it ...

... Calif., Oct. 8 Lee Shupp, executive VP,at ... evolving consumer,expectations and imaging technologies are leading to ... Future of Imaging Conference, to be,held Nov. 18-20 ... The,conference will explore the transformative impact of recent ...

... Medical Genetics (ACMG), a national nonprofit medical and ... a $13.5 million, 5-year contract from the Eunice ... Human Development (NICHD) of the National Institutes of ... Newborn Screening Translational Research Network. , "This visionary ...

Other Biology News:TheVisualMD.com launches new animated 3-D views of human body in action 2 Cheskin Added Value EVP Lee Shupp Discusses Evolving Dynamics of Consumers and Imaging Tech at 6Sight 2 American College of Medical Genetics receives $13.5M NIH contract 2

TheVisualMD.com launches new animated 3-D views of human body in action Cheskin Added Value EVP Lee Shupp Discusses Evolving Dynamics of Consumers and Imaging Tech at 6Sight American College of Medical Genetics receives $13.5M NIH contract

Protein YIPF6 (YIP1 family member 6). [Source:Uniprot/SWISSPROT;Acc:Q96EC8] Antigen: Recombinant Protein Epitope Signature Tag (PrEST)....

... U.S. sourced, ideal for those ... Low hemoglobin; Endotoxin: < 1.0 ... US origin; U.S. sourced, ideal ... uncompromising quality. Low hemoglobin Endotoxin: ...

Chicken polyclonal to ytzF ( Abpromise for all tested applications). Antigen: Full length protein...

Fetal Calf Serum Replacement (Bistec) serum...

Biology Products:

Rabbit Anti-Human YIPF6 Polyclonal Antibody, Unconjugated from Atlas Antibodies Bovine Calf Serum - 500mL from GeneTex Chicken Anti-Bacterial ytzF Polyclonal Antibody, Unconjugated from Abcam Fetal Calf Serum Replacement (Bistec) serum from Equitech-Bio

MedImmune Presents Data Highlighting its Progressive Inflammatory Disease Portfolio at the 72nd Annual Meeting of the American College of Rh...(ract: 1346 -- Neutralizing I...)